Xofluza is the first and only single-dose oral medicine for the treatment of influenza to be approved in the US for children as young as five years of age
Pfizer plans to submit an sBLA by the end of this year, subject to discussions with U.S. FDA
The partnership will accelerate stockpiling, channel distribution and hospital access for the amubarvimab/romlusevimab combination in China
Novavax' vaccine is the first protein-based COVID-19 vaccine authorized in the U.S.
Transcatheter Mitral valve procedure allows intervention on patients who are unsuitable or high risk for open heart surgery
Submission seeks approval for the treatment of COVID-19 in both vaccinated and unvaccinated individuals at high risk
The total covered market size of four brands – Z&D, Pediclory, Pecef & Ezinapi combined is Rs 1800 crores
Safety in these pediatric populations was consistent with the known safety profile across approved adult and pediatric indications1,2
Group 4 Medulloblastoma is a rare disease that mostly affects pediatric patients, in which aberrant SRC signaling was identified as a hallmark of the disease
Norliqva was approved by the FDA on February 24, 2022 and is now available through normal retail distribution.
Subscribe To Our Newsletter & Stay Updated
